Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

National Institutes of Health

Grant: National Institutes of HealthNAICS n/aSAM# RFA-NS-26-001
Posted 05/04/2026 · Response deadline 11/10/2026 · Set-aside: None

View official SAM.gov notice →

← All opportunities